Deutsche Bank Ag\ Graphite Bio, Inc. Transaction History

Deutsche Bank Ag\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.14 - $5.23 $35,393 - $86,498	-16,539 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.1 - $13.06 $34,068 - $87,240	6,680 Added 67.76%	16,539 $84,000
Q4 2021 Feb 11, 2022	BUY	$8.41 - $16.71 $4,305 - $8,555	512 Added 5.48%	9,859 $123,000
Q3 2021 Nov 04, 2021	BUY	$15.81 - $28.39 $147,776 - $265,361	9,347 New	9,347 $153,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.